Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen
TSURUOKA, Japan, June 15, 2023 /PRNewswire/ — Metagen Therapeutics (President & CEO: Taku Nakahara), a company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, has completed its Series A funding in 2 rounds, raising a total of 1.7 billion yen. Sparx Asset Management, Nippon Venture Capital, Mizuho Capital and … Read more